| Scientific Session V Chairs: B. Masri - U. Liberman
| |
| Plenary Lecture 7 Frailty and muscle metabolism dysregulation in the elderly (W. Evans)
| |
| Oral Communications 09.30-09.40 OC35
Antifracture efficacy and safety of once-yearly zoledronic acid 5 mg in men with osteoporosis: a prospective, randomized, controlled trial - S. Boonen, G. Su, E. Incera, E. Orwoll, J-M. Kaufman, J-Y. Reginster, R. Rizzoli, K. Lippuner, D. Vanderschueren, C. Bucci-Rechtweg, O. Antunez, P. Papanastasiou
09.40-09.50 OC36
Cost-effectiveness of denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women - M. Hiligsmann, J-Y. Reginster
09.50-10.00 OC37
Use of microarray technology to support development of nutraceutical supplements to reduce bone resorption and enhance bone formation - Y. Lin, S. Ramakrishnan, V. Kazlova, M. Murray, D. Fast, K. Gellenbeck, A. Chandra
| |
| Plenary Lecture 8 Emergent therapies in osteoporosis (S. Papapoulos)
| |
| Oral Communications 10.30-10.40 OC38
Four-year results of a phase 2 study of the cathespin K inhibitor odanacatib in postmenopausal women with low bone mineral density: effects on bone turnover markers - S. Papapoulos, J. Rodriguez Portales, R. Petrovic, E. Rosenberg, C. DaSilva, A. Santora, A. Lombardi, N. Binkley, H. Bone, J. Eisman, D. Hosking, B. Langdahl, M. McClung, I. Reid, H. Resch
10.40-10.50 OC39
Helicobacter pylori Cag-A positive strains negatively affect bone health: a population based study - L. Gennari, G. Martini, R. Nuti, N. Figura, D. Merlotti, M.S. Campagna, M.B. Franci, A. Avanzati, B. Lucani, A. Calabrò, S. Lardiello
10.50-11.00 OC40
Mortality risk for operated and non-operated vertebral fracture patients in the U.S. Medicare population - A. Edidin, K. Ong, E. Lau, S. Kurtz
11.00-11.10 OC41
Efficacy and safety of strontium renalate in the treatment of male osteoporosis - J.M. Kaufman, J.-D. Ringe, D. Felsenberg, M. Audran, G. Bianchi, S. Boonen, R. Josse, R.M. Francis, S. Goemaere, S. Palacios, M. Diaz Curiel
11.10-11.20 OC42
Comparing effects of kyphoplasty, vertebroplasty and nonsurgical management in a meta-analysis of randomized and nonrandomized controlled studies - I. Papanastassiou, F. Phillips, J. Van Meirhaeghe, J. Berenson, G. Andersson, G. Chung, C. Danilov, B. Small, F. Vrionis
11.20-11.30 OC43
Association between vitamin-D receptor gene polymorphisms with the risk of fractures among Saudi postmenopausal women - M-S. Ardawi, A. Rouzi, W. Faqeeh, S. Al-Sibiani, N. Al-Senani, H. Sonbol, R. Raddadi
11.30-11.40 OC44
Periostin, a matricellular glutamic-acid protein influences crosslinking of bone collagen - E. Gineyts, N. Bonnet, S. Ferrari, P. Garnero
11.40-11.50 OC45
BMD and BMC improvements in hip total, trabecular, and cortical bone following denosumab treatment: QCT results from the FREEDOM trial - H. Genant, H. Radcliffe, C. Libanati, K. Engelke, J. Zanchetta, A. Høiseth, C. Yuen, S. Stonkus, M. Bolognese, E. Franek, T. Fuerst
| |
| ESCEO-FROMO Symposium Bone repair with anti-osteoporosis medications (Chairmen: J. Goldhahn – J.A. Kanis)
- Welcome and introduction - J.-Y. Reginster
- Bone repair: Facts and challenges - J. Goldhahn.
- Preclinical evaluation of bone repair - J. Goldhahn
- Osteoporosis treatment and fracture healing - Clinical evidence - S. Boonen
- Discussion - J. Goldhahn, S. Boonen, B. Mitlak, J.M. Feron, W. Dere, S. Papapoulos, Y. Tsouderos, J.A. Kanis, J.-Y. Reginster.
| |
| Lunch Symposium - Danone Bone and musculoskeletal health during ageing: interplay of nutrition and exercise Chairmen: R. Rizzoli & A. Diez-Perez
| |
| Meet the Professor Sessions - How to improve adherence in osteoporosis (E. Dennison, MTP Room 1 - 1st floor)
- Health economics analyses in osteoporosis: from theory to practice (M. Hiligsmann, MTP Room 2 - 1st floor)
- Muscle weakness, frailty and falls (W. Evans, MTP Room 3 - 1st floor)
- Post-transplantation osteoporosis (S. Epstein, MTP Room 4 - 1st floor)
| |
| ESCEO-FROMO Symposium Adverse reactions and drug-drug interactions in the management of osteoporosis (Chairmen: R. Rizzoli - A. Diez-Perez)
- Welcome - J.-Y. Reginster
- Bisphosphonates: Adverse Reactions and Drug-Drug Interactions - C Cooper
- SERMs: Adverse Reactions and Drug-Drug Interactions - J.-M. Kaufman
- Strontium Ranelate: Adverse Reactions and Drug-Drug Interactions - J. Ringe
- Teriparatide: Adverse Reactions and Drug-Drug Interactions - A. Diez-Perez
- Denosumab: Adverse Reactions and Drug-Drug Interactions - D. Felsenberg
- Discussion Leader - A. Diez-Perez
- Summary of the ESCEO working group guidance - C. Cooper.
| |
| Meetings of the national scientific societies Current management of the osteoarthritis
- Welcome and introduction - J.-Y. Reginster (chairman)
- New proposal in the classification of OA - G. Herrero-Beaumont
- Vision of OA from the point of view of the rheumatologist and orthopaedic surgeron - Dr. P. Benito & Dr. Maculé
- Update on Diacerein - Dr. JM. Álvaro-Gracia
- Discussion and conclusions
| |
| GENERAL PRACTITIONERS SESSION (OSTEOPOROSIS WORKING GROUP OF THE SPANISH SOCIETY OF GPS) Chairman: M. Díaz Curiel
- The GPs vision of the osteoporosis clinical practice - J. San Félix
- Clinical cases presentation - C. Carbonell, C. Valdés
| |
